Human Embryonic Stem Cell (hESC)-Derived Mesenchymal Stem Cells (Mirae Cell Bio)

N/A

Report date: 2024/12/20 10:25:06

Base Information

Drug NameHuman Embryonic Stem Cell (hESC)-Derived Mesenchymal Stem Cells (Mirae Cell Bio)

Drug Alias NamehESC-Derived Mesenchymal Stem Cells (Mirae Cell Bio)MR-MC-01

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Embryonic stem cells therapyCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsCystitis, InterstitialHematopoietic stem cell transplantation (HSCT)

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesMirae Cell Bio Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesMirae Cell Bio Co Ltd

Active IndicationsN/A

Inactive IndicationsCystitis, InterstitialHematopoietic stem cell transplantation (HSCT)

Other Information

ATC CodeN/A